Sunday, 29 Nov, 2020

Health

Oxford University Covid vaccine trial paused as participant falls ill

Health Desk | banglanews24.com
Update: 2020-09-09 12:39:50
Oxford University Covid vaccine trial paused as participant falls ill Photo collected

Final clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been put on hold after a participant had an adverse reaction in the UK.

AstraZeneca described it as a "routine" pause in the case of "an unexplained illness".

The outcome of vaccine trials is being closely watched around the world.

The AstraZeneca-Oxford University vaccine is seen as a strong contender among dozens being developed globally.

Hopes have been high that the vaccine might be one of the first to come on the market, following successful phase 1 and 2 testing.

Its move to Phase 3 testing in recent weeks has involved some 30,000 participants in the US as well as in the UK, Brazil and South Africa. Phase 3 trials in vaccines often involve thousands of participants and can last several years.

Stat News, the health website which first broke the story, said details of the UK participant's adverse reaction were not immediately known, but quoted a source as saying they were expected to recover.

BDST: 1235 HRS, SEP 09, 2020
SMS

All rights reserved. Sale, redistribution or reproduction of information/photos/illustrations/video/audio contents on this website in any form without prior permission from banglanews24.com are strictly prohibited and liable to legal action.